Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells in Vitro and Controls Tumor Expansion in Vivo via Low-Affinity Activating Fc Receptors
Cancer Research - United States
doi 10.1158/0008-5472.can-07-0696
Full Text
Open PDFAbstract
Available in full text
Date
September 15, 2007
Authors
Publisher
American Association for Cancer Research (AACR)